Active Surveillance Feasible for Low-Risk Thyroid Cancer
THURSDAY, Sept. 22, 2022 (HealthDay News) — Active surveillance may be a viable strategy for...
Read More
Hematology/Oncology
Coffee Intake Linked to Longer Prostate Cancer-Specific Survival
THURSDAY, Sept. 22, 2022 (HealthDay News) — High coffee intake is associated with longer...
Read More
Transcranial Doppler, Hydroxyurea Use Low for Sickle Cell Anemia
THURSDAY, Sept. 22, 2022 (HealthDay News) — For children with sickle cell anemia (SCA),...
Read More
Combined Estrogen and Arsenic Accelerated the Neoplastic Transformation of Human Prostate Epithelial Cells
In a previous study, researchers found that estrogen and arsenic together accelerated the...
Read More
Liver Cancer Risk May Rise for 2nd-, 3rd-Generation U.S. Mexicans
TUESDAY, Sept. 20, 2022 (HealthDay News) — The risk of hepatocellular carcinoma (HCC)...
Read More
Response to Neoadjuvant Endocrine Therapy for Breast Cancer May Vary by Race
TUESDAY, Sept. 20, 2022 (HealthDay News) — The response to neoadjuvant endocrine therapy...
Read More
AI Tool Can Identify Pancreatic Cancer on CT Scans
WEDNESDAY, Sept. 21, 2022 (HealthDay News) — A deep learning (DL)-based tool may help detect...
Read More
Patient Preferences Examined for CRC Screening Modalities
WEDNESDAY, Sept. 21, 2022 (HealthDay News) — Unscreened adults aged 40 years and older at...
Read More
Medical Debt Tied to Worsening of Food, Housing Insecurity
WEDNESDAY, Sept. 21, 2022 (HealthDay News) — Medical debt is common and is a risk factor for...
Read More
Prostate cancer treatment choice among Black immigrants
Large-scale analyses of the prostate cancer (PCa) database have discovered a persistent difference...
Read More
The Role of Gene Variants in Prostate Cancer Progression: Lymphocyte Modulator, Activation, And Adhesion Genes
The presence of tumor-infiltrating lymphocytes (TILs) lends credence to the theory that prostate...
Read More
In eSCLC, PEA Represents the Most Effective First-Line Systemic Therapy
A new standard of care for eSCLC is PEA as first-line systemic therapy. There were currently no...
Read More
16P Development of A 3D Lung Cancer Model and Evaluation of Human Antibodies Directed Against Novel Targets
For a study, researchers sought to research the progression and metastasis of lung cancer; they...
Read More
In Cellular Models, Palmitoylethanolamide Co-Incubated with Doxorubicin and Trastuzumab Reduced Cardiotoxicity
N-acyl phosphatidylethanolamine phospholipase D produces palmitoylethanolamide (PEA), an...
Read More
Trastuzumab Improves the Prognosis of HER2-Positive Breast Cancer Patients
HER2-positive breast cancer patients now have a better prognosis thanks to trastuzumab. However,...
Read More
HCTRL1 Regulates Progression of Hepatocellular Carcinoma Via TTYH3/MK5 Positive Feedback Loop
For its diagnosis and treatment, hepatocellular carcinoma (HCC), one of the global causes of...
Read More
ACC Survival Prediction: 5P Application of Machine Learning Model
Although machine learning has the potential to change cancer treatment completely, it is not yet...
Read More
4P Immune Checkpoint Inhibitors in ACC
Adrenocortical carcinoma (ACC) is cancer that is uncommon, severe, and has few available...
Read More
Metastatic ACC: 3P Beyond First-line Therapy
Beyond first-line chemotherapy, there were few effective treatments for the uncommon and...
Read More
2MO EO2401 Therapeutic Vaccine for ACC and MPP Patients
EO was created to stimulate memory T cells that cross-react with antigens linked with tumor...
Read More